An FDA advisory panel is expected Thursday to recommend authorization of the COVID-19 vaccine developed by Moderna. It could be in states by Monday.
Author: Karen Weintraub, USA TODAY
FDA advisory committee to consider second COVID-19 vaccine, this one from Moderna, during all-day meeting
An FDA advisory panel is expected Thursday to recommend authorization of the COVID-19 vaccine developed by Moderna. It could be in states by Monday.
German scientist Özlem Türeci was focused on cancer at BioNTech, then came COVID-19. It was her ‘duty’ to help develop a vaccine.
When Özlem Türeci, co-founder of BioNTech, first heard about the novel coronavirus, she knew her company would have to work on a vaccine to fight it.
Effectiveness and safety of Moderna COVID vaccine confirmed, path cleared for expected authorization this week
Data released Tuesday confirms Moderna’s COVID-19 vaccine is safe and effective. FDA is expected to clear the nation’s second vaccine by week’s end.
‘A historic event for humanity’: US reaches turning point in fight against COVID-19 as FDA authorizes Pfizer vaccine
The FDA authorization clears the way for Americans to begin receiving Pfizer’s vaccine. First in line: Health care workers and nursing home residents.
The Gates Foundation adds $250M gift to fight COVID worldwide. Melinda Gates explains why.
In a wide-ranging interview with USA TODAY, Melinda Gates talks about the goal of her new donation, global health, education and finding hope.
Second dose of COVID vaccine from Pfizer or Moderna is needed, but timing doesn’t have to be exact, says government vaccine developer
Getting both shots of COVID vaccine designed as two doses is important but timing doesn’t have to be exact, Operation Warp Speed’s Moncef Slaoui says.
‘Very inconsistent’: 2 allergic reactions in the UK to COVID-19 vaccine puzzle researchers
British regulators advised people with severe allergies not to take Pfizer vaccine. One US researcher says that would be a ‘showstopper’ here.
They have masks and gloves. There’s more testing capacity. What nursing homes really need is more help, advocates say.
About a quarter of the U.S. deaths from COVID-19 – nearly 74,000 of the 280,000 total – have been nursing home residents and caregivers.
‘No surprises’: 53-page FDA report reinforces safety and effectiveness of Pfizer’s COVID-19 vaccine candidate
FDA summary on Pfizer’s candidate COVID-19 vaccine supports earlier findings that it is safe and will prevent 95% of people from becoming sick.